Literature DB >> 19590824

Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response.

Gurpreet Kaur1, Mohammad Athar, M Sarwar Alam.   

Abstract

Ferric nitrilotriacetate (Fe-NTA) is a potent nephrotoxicant and a renal carcinogen that induces its effect by causing oxidative stress. The present study was undertaken to explore protective effect of silymarin, a flavonolignan from milk thistle (Silybum marianum), against Fe-NTA mediated renal oxidative stress, inflammation and tumor promotion response along with elucidation of the implicated mechanism(s). Administration of Fe-NTA (10 mg/kg bd wt, i.p.) to Swiss albino mice induced marked oxidative stress in kidney, evident from augmentation in renal metallothionein (MT) expression, depletion of glutathione content and activities of antioxidant and phase II metabolizing enzymes, and enhancement in production of aldehyde products such as 4-hydroxy-2-nonenal. Fe-NTA also significantly activated nuclear factor kappa B (NFkappaB) and upregulated the expression of downstream genes: cyclooxygenase 2 and inducible nitric oxide synthase and enhancing the production of proinflammatory cytokines: tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6). However, feeding of 0.5% and 1% silymarin diet conferred a significant protection against Fe-NTA induced oxidative stress and inflammation. It further augmented MT expression, restored the antioxidant armory, ameliorated NFkappaB activation and decreased the expression of proinflammatory mediators. Silymarin also suppressed Fe-NTA induced hyperproliferation in kidney, ameliorating renal ornithine decarboxylase activity and DNA synthesis. From these results, it could be concluded that silymarin markedly protects against chemically induced renal cancer and acts plausibly by virtue of its antioxidant, anti-inflammatory and antiproliferative activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590824     DOI: 10.1007/s10637-009-9289-6

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  43 in total

Review 1.  The function of zinc metallothionein: a link between cellular zinc and redox state.

Authors:  W Maret
Journal:  J Nutr       Date:  2000-05       Impact factor: 4.798

2.  Evidence that Fe-NTA-induced renal prostaglandin F2 alpha is responsible for hyperplastic response in kidney: implications for the role of cyclooxygenase-dependent arachidonic acid metabolism in renal tumor promotion.

Authors:  M Iqbal; U Giri; D K Giri; M Athar
Journal:  Biochem Mol Biol Int       Date:  1997-09

3.  Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen.

Authors:  U Giri; M Iqbal; M Athar
Journal:  Int J Oncol       Date:  1999-04       Impact factor: 5.650

4.  Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress.

Authors:  T Omoya; I Shimizu; Y Zhou; Y Okamura; H Inoue; G Lu; M Itonaga; H Honda; M Nomura; S Ito
Journal:  Liver       Date:  2001-06

5.  sn-1,2-Diacylglycerols mimic the effects of 12-O-tetradecanoylphorbol-13-acetate in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis.

Authors:  R C Smart; M T Huang; A H Conney
Journal:  Carcinogenesis       Date:  1986-11       Impact factor: 4.944

6.  Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate.

Authors:  S Toyokuni; K Uchida; K Okamoto; Y Hattori-Nakakuki; H Hiai; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

7.  Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels.

Authors:  Catherine W Cheung; Paul J Taylor; Carl M J Kirkpatrick; David A Vesey; Glenda C Gobe; Clay Winterford; David L Nicol; David W Johnson
Journal:  BJU Int       Date:  2007-08       Impact factor: 5.588

8.  Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin.

Authors:  S Toyokuni; T Mori; H Hiai; M Dizdaroglu
Journal:  Int J Cancer       Date:  1995-07-28       Impact factor: 7.396

9.  Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.

Authors:  Jong S Kang; Young J Jeon; Hwan M Kim; Seung H Han; Kyu-Hwan Yang
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

Review 10.  Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?

Authors:  Mark A Hull
Journal:  Eur J Cancer       Date:  2005-09       Impact factor: 9.162

View more
  15 in total

1.  Modulation of Angiogenesis, Proliferative Response and Apoptosis by β-Sitosterol in Rat Model of Renal Carcinogenesis.

Authors:  Ramalingam Sharmila; Ganapathy Sindhu
Journal:  Indian J Clin Biochem       Date:  2016-05-24

2.  Attenuation of oxidative stress, inflammation and early markers of tumor promotion by caffeic acid in Fe-NTA exposed kidneys of Wistar rats.

Authors:  Muneeb U Rehman; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2011-06-07       Impact factor: 3.396

3.  Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis.

Authors:  Jamshid Roozbeh; Bahram Shahriyari; Masoumeh Akmali; Ghazal Vessal; Maryam Pakfetrat; Ghanbar Ali Raees Jalali; Raha Afshariani; Mahshid Hasheminasab; Nasrollah Ghahramani
Journal:  Ren Fail       Date:  2011       Impact factor: 2.606

4.  The role of heat shock protein 70 in oxidant stress and inflammatory injury in quail spleen induced by cold stress.

Authors:  Jiayi Ren; Chunpeng Liu; Dan Zhao; Jing Fu
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-15       Impact factor: 4.223

5.  Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats.

Authors:  Mehdi Nematbakhsh; Zahra Pezeshki; Behjat Alsaadat Moaeidi; Fatemeh Eshraghi-Jazi; Ardeshir Talebi; Hamid Nasri; Shahrzad Baradaran; Marjan Gharagozloo; Tahereh Safari; Maryam Haghighi
Journal:  Int J Prev Med       Date:  2013-03

6.  Amelioration of renal carcinogenesis by bee propolis: a chemo preventive approach.

Authors:  Summya Rashid; Nemat Ali; Sana Nafees; Syed Kazim Hasan; Sarwat Sultana
Journal:  Toxicol Int       Date:  2013-09

7.  "Silymarin", a promising pharmacological agent for treatment of diseases.

Authors:  Gholamreza Karimi; Maryam Vahabzadeh; Parisa Lari; Marziyeh Rashedinia; Mohammad Moshiri
Journal:  Iran J Basic Med Sci       Date:  2011-07       Impact factor: 2.699

8.  Leukemoid reaction in sarcomatoid renal cell carcinoma: a two-case report.

Authors:  Weiping Huang; Feng Wang; Yeping Li; Feifei Duan; Zhixian Yu
Journal:  World J Surg Oncol       Date:  2014-04-19       Impact factor: 2.754

9.  Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model.

Authors:  Mitra Navidi-Shishaone; Soheila Mohhebi; Mehdi Nematbakhsh; Shahla Roozbehani; Ardeshir Talebi; Zahra Pezeshki; Fatemeh Eshraghi-Jazi; Safoora Mazaheri; Sohiela Shirdavani; Marjan Gharagozloo; Behjat Alsaadat Moaeidi
Journal:  Int J Prev Med       Date:  2014-01

Review 10.  Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015.

Authors:  Hadi Darvishi Khezri; Ebrahim Salehifar; Mehrnoush Kosaryan; Aily Aliasgharian; Hossein Jalali; Arash Hadian Amree
Journal:  Adv Pharmacol Sci       Date:  2016-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.